Immunology

Making immunotherapy safe for AML

Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...

Oncology & Cancer

Study finds senescent immune cells promote lung tumor growth

Macrophages are a type of white blood cell that are among the body's first line of defense against infection. In addition to killing harmful microorganisms, macrophages typically can initiate a response against tumors. However, ...

Medications

Combining potent cancer drugs in a single multitargeting molecule

To give cancer treatments the greatest possible chance of success, patients are often treated with multiple drugs that attack the cancer using different mechanisms. A team of researchers has now combined three highly potent ...

Diseases, Conditions, Syndromes

Researchers identify driver of inflammatory bowel disease

Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for ...

Medical research

Hope for new therapy to stop advanced skin cancer

Researchers at St George's, University of London have discovered a technique that can kill skin cancer cells while minimizing damage to healthy cells. The findings are published in the journal Biology Open.

page 1 from 40